Trials / Sponsors / Immunomolecular Therapeutics, Inc.
Immunomolecular Therapeutics, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes Type1 Diabetes | Phase 1 | 2020-11-09 |